Leishmania and the macrophage
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Immunology Today
- Vol. 11 (3) , 74-75
- https://doi.org/10.1016/0167-5699(90)90029-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stageMolecular and Biochemical Parasitology, 1989
- Antibodies raised against synthetic peptides from the Arg-Gly-Asp-containing region of the Leishmania surface protein gp63 cross-react with human C3 and interfere with gp63-mediated binding to macrophagesInfection and Immunity, 1989
- Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region of the major surface glycoprotein, gp63, of Leishmania promastigotes.The Journal of Experimental Medicine, 1988
- The major surface protein of leishmania promastigotes is a fibronectin‐like moleculeEuropean Journal of Immunology, 1988
- Molecular cloning of the major surface antigen of leishmania.The Journal of Experimental Medicine, 1988
- Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum.The Journal of Experimental Medicine, 1985